カテゴリー： QYResearch, 世界

レノックスガストー症候群治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18628）・商品コード：DATA909X18628
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、レノックスガストー症候群治療の世界市場について調査・分析し、レノックスガストー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非外科的治療、外科的治療）、用途別（発作、眼球異常、EEG所見、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のレノックスガストー症候群治療市場動向
・主要企業別マーケットシェア
・レノックスガストー症候群治療の種類別市場規模2014-2019
（非外科的治療、外科的治療）
・レノックスガストー症候群治療の用途別市場規模2014-2019
（発作、眼球異常、EEG所見、その他）
・レノックスガストー症候群治療の北米市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療の中国市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療の日本国内市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療の東南アジア市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療のインド市場：主要企業・種類別/用途別市場規模
・レノックスガストー症候群治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Eisai Co., Ltd.、GlaxoSmithKline plc.、H. Lundbeck A/S、Johnson & Johnson Services, Inc.、Supernus Pharmaceuticals, Inc）
・レノックスガストー症候群治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
In 2018, the global Lennox-Gastaut Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
…

Market segment by Type, the product can be split into
Non-surgical Treatment
Surgical Treatment

Market segment by Application, split into
Seizures
Ocular Abnormality
EEG Findings
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lennox-Gastaut Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-surgical Treatment
1.4.3 Surgical Treatment
1.5 Market by Application
1.5.1 Global Lennox-Gastaut Syndrome Treatment Market Share by Application (2019-2025)
1.5.2 Seizures
1.5.3 Ocular Abnormality
1.5.4 EEG Findings
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lennox-Gastaut Syndrome Treatment Market Size
2.2 Lennox-Gastaut Syndrome Treatment Growth Trends by Regions
2.2.1 Lennox-Gastaut Syndrome Treatment Market Size by Regions (2019-2025)
2.2.2 Lennox-Gastaut Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Lennox-Gastaut Syndrome Treatment Market Size by by Players
3.1.1 Global Lennox-Gastaut Syndrome Treatment Revenue by by Players (2014-2019)
3.1.2 Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Lennox-Gastaut Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Lennox-Gastaut Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Lennox-Gastaut Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
5.2 Lennox-Gastaut Syndrome Treatment Key Players in North America
5.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Type
5.4 North America Lennox-Gastaut Syndrome Treatment Market Size by Application

6 Europe
6.1 Europe Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
6.2 Lennox-Gastaut Syndrome Treatment Key Players in Europe
6.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type
6.4 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application

7 China
7.1 China Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
7.2 Lennox-Gastaut Syndrome Treatment Key Players in China
7.3 China Lennox-Gastaut Syndrome Treatment Market Size by Type
7.4 China Lennox-Gastaut Syndrome Treatment Market Size by Application

8 Japan
8.1 Japan Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
8.2 Lennox-Gastaut Syndrome Treatment Key Players in Japan
8.3 Japan Lennox-Gastaut Syndrome Treatment Market Size by Type
8.4 Japan Lennox-Gastaut Syndrome Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
9.2 Lennox-Gastaut Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type
9.4 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application

10 India
10.1 India Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
10.2 Lennox-Gastaut Syndrome Treatment Key Players in India
10.3 India Lennox-Gastaut Syndrome Treatment Market Size by Type
10.4 India Lennox-Gastaut Syndrome Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
11.2 Lennox-Gastaut Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type
11.4 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application

12 International Players Profiles
12.1 Eisai Co., Ltd.
12.1.1 Eisai Co., Ltd. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lennox-Gastaut Syndrome Treatment Introduction
12.1.4 Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019))
12.1.5 Eisai Co., Ltd. Recent Development
12.2 GlaxoSmithKline plc.
12.2.1 GlaxoSmithKline plc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lennox-Gastaut Syndrome Treatment Introduction
12.2.4 GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.2.5 GlaxoSmithKline plc. Recent Development
12.3 H. Lundbeck A/S
12.3.1 H. Lundbeck A/S Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lennox-Gastaut Syndrome Treatment Introduction
12.3.4 H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.3.5 H. Lundbeck A/S Recent Development
12.4 Johnson & Johnson Services, Inc.
12.4.1 Johnson & Johnson Services, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lennox-Gastaut Syndrome Treatment Introduction
12.4.4 Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Services, Inc. Recent Development
12.5 Supernus Pharmaceuticals, Inc
12.5.1 Supernus Pharmaceuticals, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lennox-Gastaut Syndrome Treatment Introduction
12.5.4 Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.5.5 Supernus Pharmaceuticals, Inc Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lennox-Gastaut Syndrome Treatment Key Market Segments
Table Key Players Lennox-Gastaut Syndrome Treatment Covered
Table Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Non-surgical Treatment Figures
Table Key Players of Non-surgical Treatment
Figuer Surgical Treatment Figures
Table Key Players of Surgical Treatment
Table Global Lennox-Gastaut Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Application in 2018 & 2025
Figure Seizures Case Studies
Figure Ocular Abnormality Case Studies
Figure EEG Findings Case Studies
Figure Others Case Studies
Figure Lennox-Gastaut Syndrome Treatment Report Years Considered
Figure Global Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Lennox-Gastaut Syndrome Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Share by by Players (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by by Players in 2018
Table Global Lennox-Gastaut Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lennox-Gastaut Syndrome Treatment Product/Solution/Service
Table Date of Enter into Lennox-Gastaut Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Application in 2018
Figure North America Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table North America Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table North America Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Europe Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Europe Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Europe Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure China Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table China Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table China Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table China Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table China Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Japan Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Japan Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Japan Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure India Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table India Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table India Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table India Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table India Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Central & South America Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Table Eisai Co., Ltd. Company Details
Table Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Eisai Co., Ltd. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Eisai Co., Ltd. Recent Development
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table H. Lundbeck A/S Company Details
Table H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure H. Lundbeck A/S Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table H. Lundbeck A/S Recent Development
Table Johnson & Johnson Services, Inc. Company Details
Table Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services, Inc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Johnson & Johnson Services, Inc. Recent Development
Table Supernus Pharmaceuticals, Inc Company Details
Table Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Supernus Pharmaceuticals, Inc Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Supernus Pharmaceuticals, Inc Recent Development
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Share by Regions in 2025
Figure North America Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Product in 2025
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Eisai Co., Ltd.、GlaxoSmithKline plc.、H. Lundbeck A/S、Johnson & Johnson Services, Inc.、Supernus Pharmaceuticals, Inc

★調査レポート[レノックスガストー症候群治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18628)販売に関する免責事項を必ずご確認ください。
★調査レポート[レノックスガストー症候群治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18542 / QYResearch / 2019年11月25日 / ※当調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場について調査・分析し、HIV関連リポジストロフィー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（特定薬物治療、美容矯正治療）、用途別（病院、専門医院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のHIV関連リポジストロフィー症候群治療市場動向 ・主要企業別マーケットシェア ・HIV関連リポジストロフィー症候群治療の種類別市場規模2014-2019 （特定薬物治療、美容矯正治療） ・HIV関連リポジストロフィー症候群治療の用途別市場規模2014-2019 （病院、専門医院、その他） ・HIV関連リポジストロフィー症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・HIV関連リポジストロフィー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global HIV Associated Lipodystrophy Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Associated Lipodystrophy Syndrome Treatment development in North America, Europe and Asia-Pacific. The key players covered in this...
  • 多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18844 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群治療市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019 （経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬） ・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019 （病院薬局、ドラッグストア） ・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and...

    • ◆H&Iグローバルリサーチのお客様（例）◆